A Comparative Study of Pancreaticoduodenectomy for Benign and Malignant Disease.
- Author:
Kwang Dae HONG
1
;
Gun Young BYUN
;
Yoon Jung BOO
;
Tae Jin SONG
;
Young Chul KIM
;
Sung Ock SUH
Author Information
1. Department of Surgery, Korea University College of Medicine, Seoul, Korea. docsuh@chollian.net
- Publication Type:Comparative Study ; Original Article
- Keywords:
Gastric cancer Hepatectomy Prognosis;
Benign;
Malignant
- MeSH:
Follow-Up Studies;
Humans;
Incidence;
Jaundice;
Length of Stay;
Mortality;
Pancreatic Diseases;
Pancreaticoduodenectomy*;
Pancreatitis, Chronic;
Perioperative Care;
Postoperative Complications;
Reoperation;
Retrospective Studies;
Weight Loss
- From:Korean Journal of Hepato-Biliary-Pancreatic Surgery
2006;10(2):23-28
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The mortality and morbidity rate after pancreaticoduodenectomy (PD) is still high, although the operative techniques and skills and the perioperative care has been improved. The incidence of PD for benign disease is 5~20%. The aim of this study is to determine the factors that differentiate between the benign group and the malignant group by comparing the clinical manifestations, and we studied the safety of performing PD for benign diseases by observing the early and late postoperative complications. METHODS: We retrospectively studied 124 patients who had been diagnosed with benign or malignant pancreatic diseases and who underwent PD between April 1995 and December 2005. We divided the patients into two groups, i.e., the benign group (20) and the malignant group (104), to compare their clinical characteristics and postoperative outcomes. Result: Chronic pancreatitis was the most common disease (35%) in the benign group and distal CBD cancer was the most common disease (40.4%) in the malignant group. Jaundice, weight loss, and elevation of CA 19-9 were more frequent in the malignant group than in the benign group (p<0.05). There were no statistical differences in the mortality rate (10.0% vs 6.7%), reoperation rate (5.0% vs 4.8%), hospital stays (27.1 days vs 24.0 days), early complications (30.0% vs 44.6%) and late complications (22.2% vs 26.4%) between the two groups. There were no mortality and newly developed malignancy during 33.4 months of follow-up period in benign group. CONCLUSION: On the preoperative evaluation, jaundice, weight loss, and elevation of CA 19-9 were more frequent in the malignant group. The postoperative early and late complications showed no difference between the two groups and complication rate was generally favorable. Thus, PD can be performed safely for benign diseases that cannot be treated in a conservative fashion and also for other clinically suspicious malignant diseases.
